Results
In group 1 (lymphoma patients), 13 cases were found to have a Pi MZ phenotype (5.8%). One patient with a Pi SS phenotype and three patients with an abnormal unknown phenotype, characterised by migration slower than Z, were also detected in this group. The serological and histological data on these 17 patients are summarised in Table 1 . In the non-Hodgkin's lymphoma subgroup, five cases presented with paraproteinaemia. All of them had a Pi M phenotype.
In group 2 (controls), the Pi MZ phenotype was detected in five of 250 individuals (2%).
The incidence of other phenotypes and the comparison of frequencies between the two groups are given in Table 2 . 
Discussion
Originally the Z allele of a,AT has been related with lung and liver pathology. Later on a variety of inflammatory disorders and immunopathological conditions, including lymphomas with paraproteinaemia,5 have been described in association with the Pi MZ phenotype.7 Moreover, there is good evidence that a,AT is involved in the regulation of the immune system.8 To evaluate the incidence of abnormal Pi phenotypes in malignant lymphomas, a Pi phenotyping was performed in 250 healthy blood donors and compared with that obtained in 228 unselected consecutive lymphoma patients.
In the control group (blood donors), five of 250 individuals presented with a Pi MZ phenotype (2%). This incidence is similar to the reported incidence in other European studies.9 10 No Pi SS or abnormal unknown phenotypes were found in this group. In the lymphoma group, 13 patients (7 Morbus Hodgkin's, 6 non-Hodgkin's lymphomas) were found to have a Pi MZ phenotype (5.8%). Furthermore, one patient of this group showed a Pi SS and three other cases were characterised by the presence of an abnormal unknown phenotype with a band slower than Z, probably corresponding to the recently described YPratt." In order to confirm this correspondence, further investigations, including family studies, are needed.
These data point to an increased incidence of abnormal Pi phenotypes (MZ, SS, unknown migrating slower than Z) in lymphoma patients with no prevalence for a special subgroup (Tables 1 and 2 ).
Absolute comparisons of frequencies were difficult to perform because of the heterogeneity and the small sample size within phenotypic groups. However, when abnormal Pi phenotypes (MZ, SS, unknown) were analysed as a whole, their incidence was statistically significant (p < 0.01); when the Pi MZ phenotype was separately analysed, its incidence was just significant (p 0.05) ( Table 2 ). In this study no patient presenting with paraproteinaemia could be recognised as having abnormal Pi phenotypes. The Pi MZ and SS phenotypes are usually associated with a reduced serum level of cx,AT.'2 However, because of the acute reactant nature of this protein, its serum concentration may change dramatically in the presence of inflammatory processes and malignant tumoral proliferations.' This might explain the variety of a ,AT serum concentrations found in the patients of this study. The 
